Precision Biosensor, Inc. (335810.KQ)
KOSDAQ · KRW · Healthcare · Medical Devices
₩1,477 (+2.07%) as of
Key statistics
- Market cap
- 32.31B
- Dividend yield
- 0.00%
- 52-week range
- 1,106.00 – 3,505.00
- Beta
- 0.40
- Revenue (TTM)
- 23.66B
- Profit margin
- -26.85%
- Volume
- 1.82k
About Precision Biosensor, Inc.
Precision Biosensor, Inc. engages in the development, production, and sale of immune diagnostic kits in South Korea. It offers Exdia TRF Plus, an immunodiagnosis POCT platform; and Exdia PT10 and Exdia PT10S, a clinical chemistry POCT platform. The company was founded in 2009 and is headquartered in Daejeon, South Korea.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Daejeon, South Korea
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.